Lifestyle Promotion Intervention for Obesity
(CIRCUIT Trial)
Trial Summary
What is the purpose of this trial?
The Dyn@mo lifestyle intervention (CHU Sainte-Justine, Quebec, Canada) targets children and adolescents aged 6 to 17 years old with cardiometabolic risk factors, such as obesity, hypertension, disorders in glucose regulation or dyslipidemia. Its primary goal is to promote physical activity and reduce sedentary time to improve childrens' cardiometabolic profile. To do so, the intervention relies on gathering data on mobility and physical activity using wearable sensors. These data provide a detailed picture of real-life conditions and physical activity levels, improving the health care professional's ability to tailor counseling. The investigators are presently in the implementation phase of this intervention.
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications.
What data supports the effectiveness of the treatment Sensor based PA intervention, Dyn@mo lifestyle intervention, Sensor-based Physical Activity Intervention, Traditional PA counseling, Physical Activity Counseling, Lifestyle Intervention for obesity?
Research shows that lifestyle interventions, which include support for changing diet and physical activity, are effective for weight loss and are considered the first line treatment for obesity. Digital self-monitoring of diet and physical activity has also been found to significantly support weight loss and improve physical activity in adults with obesity.12345
Is the Lifestyle Promotion Intervention for Obesity safe for humans?
How is the Sensor-based Physical Activity Intervention for obesity different from other treatments?
Eligibility Criteria
The Dynamo trial is for children and teens aged 6 to 17 with obesity, specifically those with a BMI over the 95th percentile for their age and sex. It's not suitable for kids who have physical or mental health issues that would limit their ability to be active.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Implementation
Participants undergo the Dyn@mo lifestyle intervention, which includes wearing sensors to gather data on mobility and physical activity for a tailored plan
Follow-up
Participants are monitored for changes in cardiometabolic risk factors such as blood pressure, lipid status, BMI, and glucose homeostasis
Treatment Details
Interventions
- Sensor based PA intervention (Behavioral Intervention)
- Traditional PA counseling (Behavioral Intervention)
Sensor based PA intervention is already approved in Canada for the following indications:
- Cardiometabolic risk factors in children and adolescents
- Obesity
- Hypertension
- Disorders in glucose regulation
- Dyslipidemia